Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
OLX-75016 by OliX Pharmaceuticals for Liver Fibrosis: Likelihood of Approval
OLX-75016 is under clinical development by OliX Pharmaceuticals and currently in Phase I for Liver Fibrosis. According to GlobalData, Phase...
OLX-75016 by OliX Pharmaceuticals for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Likelihood of Approval
OLX-75016 is under clinical development by OliX Pharmaceuticals and currently in Phase I for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)....
OLX-75016 by OliX Pharmaceuticals for Metabolic Dysfunction-Associated Steatohepatitis (MASH): Likelihood of Approval
OLX-75016 is under clinical development by OliX Pharmaceuticals and currently in Phase I for Metabolic Dysfunction-Associated Steatohepatitis (MASH). According to...
OLX-75016 by OliX Pharmaceuticals for Liver Cirrhosis: Likelihood of Approval
OLX-75016 is under clinical development by OliX Pharmaceuticals and currently in Phase I for Liver Cirrhosis. According to GlobalData, Phase...